• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性运动神经病静脉注射免疫球蛋白治疗后肌肉力量改善的模式。

Pattern of muscle strength improvement after intravenous immunoglobulin therapy in multifocal motor neuropathy.

机构信息

Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.

Department of Rehabilitation, Physical Therapy Science & Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Muscle Nerve. 2021 May;63(5):678-682. doi: 10.1002/mus.27185. Epub 2021 Feb 9.

DOI:10.1002/mus.27185
PMID:33501670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8247955/
Abstract

INTRODUCTION

In multifocal motor neuropathy (MMN), knowledge about the pattern of treatment response in a wide spectrum of muscle groups, distal as well as proximal, after intravenous immunoglobulin (IVIg) initiation is lacking.

METHODS

Hand-held dynamometry data of 11 upper and lower limb muscles, from 47 patients with MMN was reviewed. Linear mixed models were used to determine the treatment response after IVIg initiation and its relationship with initial muscle weakness.

RESULTS

All muscle groups showed a positive treatment response after IVIg initiation. Changes in SD scores ranged from +0.1 to +0.95. A strong association between weakness at baseline and the magnitude of the treatment response was found.

DISCUSSION

Improved muscle strength in response to IVIg appears not only in distal, but to a similar degree also in proximal muscle groups in MMN, with the largest response in muscle groups that show the greatest initial weakness.

摘要

简介

在多灶性运动神经病(MMN)中,对于静脉注射免疫球蛋白(IVIg)治疗开始后,广泛的肌肉群(包括远端和近端肌肉)的治疗反应模式,缺乏了解。

方法

回顾了 47 例 MMN 患者的 11 个上肢和下肢肌肉的手持式测力计数据。使用线性混合模型来确定 IVIg 治疗开始后的治疗反应及其与初始肌肉无力的关系。

结果

IVIg 治疗开始后,所有肌肉群均显示出阳性的治疗反应。SD 评分的变化范围为+0.1 至+0.95。在基线时的无力程度与治疗反应的幅度之间存在很强的关联。

讨论

对 IVIg 的治疗反应,不仅在远端肌肉中有所改善,而且在 MMN 中也在类似程度上在近端肌肉群中有所改善,在最初无力程度最大的肌肉群中反应最大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/8247955/385f628fcac3/MUS-63-678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/8247955/385f628fcac3/MUS-63-678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/8247955/385f628fcac3/MUS-63-678-g001.jpg

相似文献

1
Pattern of muscle strength improvement after intravenous immunoglobulin therapy in multifocal motor neuropathy.多发性运动神经病静脉注射免疫球蛋白治疗后肌肉力量改善的模式。
Muscle Nerve. 2021 May;63(5):678-682. doi: 10.1002/mus.27185. Epub 2021 Feb 9.
2
Do A-waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block?A 波能否预测无阻滞性多灶运动神经病的静脉免疫球蛋白反应?
Muscle Nerve. 2011 Apr;43(4):537-42. doi: 10.1002/mus.21914. Epub 2011 Feb 8.
3
Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.静脉注射免疫球蛋白在多发性运动神经病中的药代动力学。
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1145-8. doi: 10.1136/jnnp-2013-306227. Epub 2013 Dec 11.
4
Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index.使用运动单位数量指数监测静脉注射免疫球蛋白治疗多灶性运动神经病的短期疗效。
Clin Neurophysiol. 2017 Jan;128(1):235-240. doi: 10.1016/j.clinph.2016.11.012. Epub 2016 Dec 1.
5
Childhood-onset multifocal motor neuropathy with conduction blocks.儿童期起病的多灶性运动神经病伴传导阻滞
Neurology. 2006 Mar 28;66(6):922-4. doi: 10.1212/01.wnl.0000203346.25068.3f.
6
Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.多灶性运动神经病:长期静脉注射免疫球蛋白后传导阻滞减少及神经再支配
Neurology. 2004 Oct 12;63(7):1264-9. doi: 10.1212/01.wnl.0000140497.85952.fa.
7
A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.多灶性运动神经病患者从静脉注射免疫球蛋白到皮下免疫球蛋白治疗的平稳过渡方案:一项开放性概念验证研究。
J Peripher Nerv Syst. 2011 Jun;16(2):92-7. doi: 10.1111/j.1529-8027.2011.00330.x.
8
Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.静脉注射免疫球蛋白治疗多灶性运动神经病的维持治疗:一项多中心、开放标签、52 周 3 期临床试验。
J Peripher Nerv Syst. 2018 Jun;23(2):115-119. doi: 10.1111/jns.12268. Epub 2018 Apr 24.
9
[Analysis of the clinical and electrophysiological characteristics of multifocal motor neuropathy].[多灶性运动神经病的临床及电生理特征分析]
Zhonghua Nei Ke Za Zhi. 2017 Nov 1;56(11):842-845. doi: 10.3760/cma.j.issn.0578-1426.2017.11.013.
10
New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.新型液体静脉注射免疫球蛋白(10% IVIg)治疗多灶性运动神经病:一项关于疗效、安全性和耐受性的前瞻性研究。
J Neurol. 2008 Oct;255(10):1598-9. doi: 10.1007/s00415-008-0979-3. Epub 2008 Sep 3.

引用本文的文献

1
Multifocal Motor Neuropathy: A Narrative Review.多灶性运动神经病:一篇叙述性综述
Muscle Nerve. 2025 Apr;71(4):512-534. doi: 10.1002/mus.28349. Epub 2025 Feb 12.

本文引用的文献

1
Immunoglobulin therapy in the treatment of multifocal motor neuropathy.免疫球蛋白疗法治疗多灶性运动神经病
J Neurol Sci. 2017 Apr 15;375:190-197. doi: 10.1016/j.jns.2017.01.061. Epub 2017 Jan 25.
2
The pathogenesis of multifocal motor neuropathy and an update on current management options.多灶性运动神经病的发病机制及当前治疗选择的最新进展。
Ther Adv Neurol Disord. 2015 May;8(3):109-22. doi: 10.1177/1756285615575269.
3
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.静脉注射免疫球蛋白治疗多灶性运动神经病的对照试验。
J Peripher Nerv Syst. 2013 Dec;18(4):321-30. doi: 10.1111/jns5.12046.
4
Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review.手持式测力计与金标准等速测力法的相关性:系统评价。
PM R. 2011 May;3(5):472-9. doi: 10.1016/j.pmrj.2010.10.025.
5
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.欧洲神经病学会联合会/周围神经学会多发性运动神经病管理指南。欧洲神经病学会联合会和周围神经学会联合工作组的报告——第一次修订版。
J Peripher Nerv Syst. 2010 Dec;15(4):295-301. doi: 10.1111/j.1529-8027.2010.00290.x.
6
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.88 例多灶性运动神经病患者静脉注射免疫球蛋白治疗的结局和反应的相关性。
Neurology. 2010 Aug 31;75(9):818-25. doi: 10.1212/WNL.0b013e3181f0738e.
7
Functioning of patients with multifocal motor neuropathy.多灶性运动神经病患者的功能。
J Peripher Nerv Syst. 2010 Jun;15(2):113-9. doi: 10.1111/j.1529-8027.2010.00259.x.
8
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.多灶性运动神经病中皮下注射与静脉注射免疫球蛋白的比较:一项随机、单盲交叉试验。
Eur J Neurol. 2009 May;16(5):631-8. doi: 10.1111/j.1468-1331.2009.02568.x. Epub 2009 Feb 19.
9
Axon loss is an important determinant of weakness in multifocal motor neuropathy.轴突丢失是多灶性运动神经病中肌无力的一个重要决定因素。
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):743-7. doi: 10.1136/jnnp.2005.064816.
10
Comparison of maximal voluntary isometric contraction and hand-held dynamometry in measuring muscle strength of patients with progressive lower motor neuron syndrome.最大自主等长收缩与手持测力计在测量进行性下运动神经元综合征患者肌肉力量中的比较。
Neuromuscul Disord. 2003 Nov;13(9):744-50. doi: 10.1016/s0960-8966(03)00135-4.